< Back to previous pagePublication ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation Journal Contribution - Journal ArticleJournal: EMBO JOURNALISSN: 1460-2075Issue: 3Volume: 40DOI: https://doi.org/10.15252/embj.2020105784Handle: http://hdl.handle.net/1854/LU-8686831WoS Id: 000605423000001 Accessibility:OpenAuthors/publisherMarcus Borenäs (Author)Ganesh Umapathy (Author)WeiU+2010Yun Lai (Author)Dan E Lind (Author)Barbara Witek (Author)Jikui Guan (Author)Patricia MendozaU+2010Garcia (Author)Tafheem Masudi (Author)Arne Claeys (Author)TzuU+2010Po Chuang (Author)Abeer El Wakil (Author)Badrul Arefin (Author)Susanne Fransson (Author)Jan Koster (Author)Mathias Johansson (Author)Jennie Gaarder (Author)Jimmy Van den Eynden (Author)Bengt Hallberg (Author)Ruth H Palmer (Author)Research unitsDepartment of Human Structure and Repair(Department)Ghent University